On June 4, IBM fell 3.77% overnight, trading at $293.22/share, with trading volume of $6,760.18. The decline reflects continued profit-taking pressure as the stock has accumulated approximately 40% gains since May, prompting bulls to lock in profits.
On the news front, despite bullish analyst actions — Wedbush Securities raised its target price from $320 to $350 while reiterating an Outperform rating, and Citigroup lifted its target from $285 to $375 — the outsized prior rally has weighed on sentiment. Analysts noted that IBM's leadership in AI and quantum computing remains underappreciated by the market.
On the fundamental side, IBM recently disclosed plans to invest over $10 billion in quantum computing over the next five years, targeting the launch of its first large-scale fault-tolerant quantum computer by 2029. The company also received approximately $1 billion in U.S. Commerce Department funding under the CHIPS and Science Act to establish Anderon, described as America's first dedicated quantum chip foundry. IBM has deployed over 90 quantum computing systems, exceeding the combined total of all other industry participants.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments